European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - oclacitinib maleate - agents for dermatitis, excluding corticosteroids - dogs - - treatment of pruritus associated with allergic dermatitis in dogs.- treatment of clinical manifestations of atopic dermatitis in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - horses; pigs; cattle - cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy. for the relief of post-operative pain following dehorning in calves.pigsfor the reduction of symptoms of lameness and inflammation in non-infectious locomotor disorders and for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.horsesfor use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders. for the relief of pain associated with equine colic.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - cefovecin (as sodium salt) - antibacterials for systemic use - dogs; cats - dogsfor the treatment of skin and soft-tissue infections including pyoderma, wounds and abscesses associated with staphylococcus pseudintermedius, β-haemolytic streptococci, escherichia coli and / or pasteurella multocida.for the treatment of urinary-tract infections associated with escherichia coli and / or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with porphyromonas spp. and prevotella spp.catsfor the treatment of skin and soft-tissue abscesses and wounds associated with pasteurella multocida, usobacterium spp., bacteroides spp., prevotella oralis, β-haemolytic streptococci and / or staphylococcus pseudintermedius.for the treatment of urinary-tract infections associated with escherichia coli.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibacterials for systemic use - pigs; cattle; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis sensitive to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. draxxin should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated west nile virus, strain vm-2 - immunologicals for equidae - horses - for the active immunisation of horses of six months of age or older against west-nile-virus disease by reducing the number of viraemic horses.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa  - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - immunologicals - cats - for the active immunisation of healthy cats nine weeks or older against feline panleukopenia and feline leukaemia viruses and against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and chlamydophila felis.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - immunologicals for suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. another key contributor to boar taint, skatole, may also be reduced as an indirect effect. aggressive and sexual (mounting) behaviours are also reduced.female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - ceftiofur - antibacterials for systemic use - pigs; cattle - pigstreatment of bacterial respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and streptococcus suis.treatment of septicaemia, polyarthritis or polyserositis associated with streptococcus suis infection.cattletreatment of acute interdigital necrobacillosis in cattle also known as panaritium or foot rot.treatment of acute post-partum (puerperal) metritis in cattle, in cases where treatment with another antimicrobial has failed.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - toceranib - antineoplastic agents - dogs - treatment of non-resectable patnaik grade-ii (intermediate-grade) or -iii (high-grade), recurrent, cutaneous mast-cell tumours in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - pirlimycin - antibacterials for intramammary use - cattle - for the treatment of subclinical mastitis in lactating cows due to gram-positive cocci susceptible to pirlimycin including staphylococcal organisms such as staphylococcus aureus, both penicillinase-positive and penicillinase-negative, and coagulase-negative staphylococci; streptococcal organisms including streptococcus agalactiae, streptococcus dysgalactiae and streptococcus uberis.